Bandingkan Harga & Kinerja Maharaksa Biru Energi Tbk. (OASA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Maharaksa Biru Energi Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Maharaksa Biru Energi Tbk. diperdagangkan di Rp306 (kapitalisasi pasar 1,98 T, volume 24 jam 18,6 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Maharaksa Biru Energi Tbk. jauh lebih besar — sekitar 11,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Maharaksa Biru Energi Tbk. lebih aktif diperdagangkan (18,6 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OASA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,98 T | 166,01 M |
Volume | 18,6 jt | 324 rb |
Lot | 186,03 rb | 3,24 rb |
Perputaran | 5,71 M | 77,68 jt |
Harga Rata-rata | 306,76 | 239,75 |
Nilai Transaksi | 5,71 M | 77,68 jt |
Harga Ekuilibrium Indikatif | 306 | 240 |
Volume Ekuilibrium Indikatif | 8,82 rb | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Maharaksa Biru Energi Tbk.
PT. Protech Mitra Perkasa Tbk (the Company) was established on April 20, 2006 based on the Notarial Deed No. 72 of Mellyani Noor Shandra S.H. The Company is starting as general trading and contracting company, the company continue to grow and build a solid reputation within the telecommucication industry. Complementing its trade and construction business, in 2013, the Company extends its services by providing managed services for Telco Towers through its full subsidiary, Telesys Indonesia.
Selengkapnya di halaman OASA →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
